The Swiss Diabetes Venture Fund (SDVF) brings together a unique constellation of partners to invest with impact globally in exceptional diabetes technology startups. Leveraging the power, knowhow and networks of Serpentine Ventures, the investment arm of the Swiss Ventures Group, and the DCB, a global center for technology innovation in diabetes.